Synspira

United States
Panora, Iowa, United States

Company profile

Synspira company profile

Synspira Therapeutics is focused on developing a rationally designed portfolio of products in cystic fibrosis and other rare diseases. Inspired by patients and frustrated by the limitations of conventional treatments, Synspira is advancing two novel products (SNSP113 and SNSP003) in order to provide better clinical outcomes and reduce treatment burden in Progressive Pulmonary Disease and Malabsorption Syndromes.

Business identity

Contact email
[email protected]
Phone number
(781) 235-3060
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$22.2M
Last funding
Series Unknown / $14M / 2020-10-20
Last equity funding
Series Unknown / $14M
Investors
2
Lead investors
1
Founders
1
Articles
3

Founders and investors

Founders

Shenda Baker

Lead investors

Cystic Fibrosis Foundation

Investors

Cystic Fibrosis FoundationMiller Family Trust